Company News
Weekly review
The FTSE 100 ended the week down 19. 55 points, or 0. 26%, closing at 7,615. 54 on Friday.
Director dealings: Ceres Power chair invests, Wise CFO covers expenses
Two significant director dealings were disclosed to the market by Ceres Power and Wise on Friday, shedding light on transactions involving their key personnel.
Mosman raises £0.3m to bolster working capital
Mosman Oil and Gas had raised £0. 3m, it announced on Friday, through the placing of 2,400,000,000 shares.
Parkmead reports progress at LDS-01 well
Independent energy firm Parkmead updated the market on its gas production following the successful start of production from the LDS-01 well in the fourth quarter of 2023.
Orchard Funding warns of impact of GAP product withdrawals
Insurance premium financing specialist Orchard Funding Group updated the market on the guaranteed asset protection (GAP) insurance market on Friday, after a review by the Financial Conduct Authority (FCA).
Wizz Air surges on Jan passenger numbers, route reinstatement
Shares in Wizz Air surged on Friday as the low-cost airline reinstated routes to the Middle East and reported a 14. 2% rise in January passenger numbers but load factor fell due to the conflict in Gaza and an increase in one-way traffic.
Aukett Swanke records higher full-year profit
Building, architectural and design service provider Aukett Swanke said in an update on Friday that, based on unaudited management accounts, it recorded a small pre-tax profit for the year ended 30 September, excluding exceptional items related to acquisitions.
Wishbone Gold raises £0.3m in 'top-up' placing
Wishbone Gold announced on Friday that it has successfully raised £0. 3m in funding from a corporate investor, selling 25 million new shares for 1. 2p each.
TSB to cut jobs, close branches
TSB is to cut jobs and close branches as part of a restructuring plan announced by its Spanish parent Banco Sabadell.
BP appoints Kate Thomson as its permanent finance chief
BP announced the appointment of Kate Thomson as its new, permanent chief financial officer on Friday, effective immediately.
Jaguar Land Rover Q3 profits motor ahead on higher orders
UK luxury car maker Jaguar Land Rover posted its highest quarterly profit in six years driven by higher client orders and wholesale revenue.
Annual profits top $36bn at ExxonMobil
ExxonMobil posted above-forecast earnings on Friday, as increased production helped offset a decline in energy prices.
Superdry CEO Dunkerton considering takeover, shares rocket
Superdry shares rocketed on Friday after it said chief executive Julian Dunkerton is considering making an offer for the fashion brand and is currently in talks with potential sources of finance.
BAT, Philip Morris settle patent infringement litigations over heated tobacco, vapour products
British American Tobacco said on Friday that it has reached a global settlement with Philip Morris International to resolve all ongoing patent infringement litigations between the two related to its heated tobacco and vapour products.
Chevron earnings slide amid record shareholder returns
Chevron reported fourth-quarter earnings of $2. 3bn on Friday, or $1. 22 per share on a diluted basis, down from $6. 4b and $3. 33 per share a year earlier.
Citi trims estimates on BT, reiterates 'buy' rating
Citi has trimmed its fourth-quarter estimates for BT Group while reiterating its ‘buy’ rating.
Diageo kicks off search for new chairman - report
Drinks giant Diageo has reportedly kicked off the search for a new chairman as it grapples with a sharp slowdown in sales in key growth markets.
Pan African Resources flags strong rise in earnings
Pan African Resources reported a substantial increase in headline earnings per share and earnings per share in its first half on Friday, to between 2. 14 and 2. 3 cents per share, up from 1. 52 cents per share for the same period in 2022.
YouGov reiterates outlook despite 'challenging' conditions
YouGov confirmed its full-year outlook on Friday, despite "challenging" economic conditions weighing on client budgets.
Hutchmed partner Inmagene exercises options over two drug candidates
Hutchmed China announced on Friday that Inmagene Biopharmaceuticals has exercised options to licence two drug candidates, IMG-007 and IMG-004, as part of their strategic partnership.